Literature DB >> 21865860

Higher infiltration by Th17 cells compared with regulatory T cells is associated with severe acute T-cell-mediated graft rejection.

Byung Ha Chung1, Hye Jwa Oh, Shang Guo Piao, In O Sun, Seok Hui Kang, Sun Ryoung Choi, Hoon Suk Park, Bum Soon Choi, Yeong Jin Choi, Cheol Whee Park, Yong Soo Kim, Mi La Cho, Chul Woo Yang.   

Abstract

The aim of this study was to evaluate whether the Th17 and Treg cell infiltration into allograft tissue is associated with the severity of allograft dysfunction and tissue injury in acute T cell-mediated rejection (ATCMR). Seventy-one allograft tissues with biopsy-proven ATCMR were included. The biopsy specimens were immunostained for FOXP3 and IL-17. The allograft function was assessed at biopsy by measuring serum creatinine (Scr) concentration, and by applying the modified diet in renal disease (MDRD) formula, which provides the estimated glomerular filtration rate (eGFR). The severity of allograft tissue injury was assessed by calculating tissue injury scores using the Banff classification. The average numbers of infiltrating Treg and Th17 cells were 11.6 ± 12.2 cells/mm² and 5.6 ± 8.0 cells/mm², respectively. The average Treg/Th17 ratio was 5.6 ± 8.2. The Treg/Th17 ratio was significantly associated with allograft function (Scr and MDRD eGFR) and with the severity of interstitial injury and tubular injury (P < 0.05, all parameters). In separate analyses of the number of infiltrating Treg and Th17 cells, Th17 cell infiltration was significantly associated with allograft function and the severity of tissue injury. By contrast, Treg cell infiltration was not significantly associated with allograft dysfunction or the severity of tissue injury. The results of this study show that higher infiltration of Th17 cell compared with Treg cell is significantly associated with the severity of allograft dysfunction and tissue injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865860      PMCID: PMC3249589          DOI: 10.3858/emm.2011.43.11.071

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  40 in total

Review 1.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 2.  Developmental plasticity of Th17 and Treg cells.

Authors:  Yun Kyung Lee; Ryuta Mukasa; Robin D Hatton; Casey T Weaver
Journal:  Curr Opin Immunol       Date:  2009-06-11       Impact factor: 7.486

3.  IL-17-producing human peripheral regulatory T cells retain suppressive function.

Authors:  Gaëlle Beriou; Cristina M Costantino; Charles W Ashley; Li Yang; Vijay K Kuchroo; Clare Baecher-Allan; David A Hafler
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

Review 4.  The T helper 17-regulatory T cell axis in transplant rejection and tolerance.

Authors:  Peter Mitchell; Behdad Afzali; Giovanna Lombardi; Robert I Lechler
Journal:  Curr Opin Organ Transplant       Date:  2009-08       Impact factor: 2.640

5.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Authors:  Kui Shin Voo; Yui-Hsi Wang; Fabio R Santori; Cesar Boggiano; Yi-Hong Wang; Kazuhiko Arima; Laura Bover; Shino Hanabuchi; Jahan Khalili; Ekaterina Marinova; Biao Zheng; Dan R Littman; Yong-Jun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

Review 6.  Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis.

Authors:  Kiran Nistala; Lucy R Wedderburn
Journal:  Rheumatology (Oxford)       Date:  2009-03-05       Impact factor: 7.580

7.  The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.

Authors:  L W Gaber; T J Schroeder; L W Moore; M H Shakouh-Amiri; A O Gaber
Journal:  Transplantation       Date:  1996-06-27       Impact factor: 4.939

8.  T(H)17 versus Treg cells in renal transplant candidates: effect of a previous transplant.

Authors:  D San Segundo; M López-Hoyos; G Fernández-Fresnedo; M J Benito; J C Ruiz; A Benito; E Rodrigo; M Arias
Journal:  Transplant Proc       Date:  2008-11       Impact factor: 1.066

9.  Interleukin-17 and kidney allograft outcome.

Authors:  J C O Crispim; R Grespan; G Martelli-Palomino; D M Rassi; R S Costa; L T Saber; F Q Cunha; E A Donadi
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

Review 10.  TH17 cells and regulatory T cells in primary immunodeficiency diseases.

Authors:  Hans D Ochs; Mohamed Oukka; Troy R Torgerson
Journal:  J Allergy Clin Immunol       Date:  2009-05       Impact factor: 10.793

View more
  11 in total

1.  The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.

Authors:  Kyoung Woon Kim; Byung Ha Chung; Bo-Mi Kim; Mi-La Cho; Chul Woo Yang
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

2.  Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.

Authors:  J A Sullivan; E Jankowska-Gan; S Hegde; M A Pestrak; V V Agashe; A C Park; M E Brown; J F Kernien; D S Wilkes; D B Kaufman; D S Greenspan; W J Burlingham
Journal:  Am J Transplant       Date:  2016-12-19       Impact factor: 8.086

3.  Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL-17A.

Authors:  Ravi Dhital; Shashi Anand; Brianna Graber; Qiang Zeng; Victoria M Velazquez; Srinivasa R Boddeda; James R Fitch; Ranjana W Minz; Mukut Minz; Ashish Sharma; Rachel Cianciolo; Masako Shimamura
Journal:  Am J Transplant       Date:  2022-06-15       Impact factor: 9.369

4.  Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction.

Authors:  Byung Ha Chung; Kyoung Woon Kim; Bo-Mi Kim; Kyoung Chan Doh; Mi-La Cho; Chul Woo Yang
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

Review 5.  Clinical significance of Th17 cells in kidney transplantation.

Authors:  Byung Ha Chung; Chul Woo Yang; Mi-La Cho
Journal:  Korean J Intern Med       Date:  2018-05-31       Impact factor: 2.884

6.  Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression.

Authors:  Byung Ha Chung; Kyoung Woon Kim; Bo-Mi Kim; Shang Guo Piao; Sun Woo Lim; Bum Soon Choi; Cheol Whee Park; Yong-Soo Kim; Mi-La Cho; Chul Woo Yang
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

7.  Histopathological analysis of infiltrating T cell subsets in acute T cell-mediated rejection in the kidney transplant.

Authors:  Francisco Salcido-Ochoa; Susan Swee-Shan Hue; Siyu Peng; Zhaoxiang Fan; Reiko Lixiang Li; Jabed Iqbal; John Carson Allen; Alwin Hwai Liang Loh
Journal:  World J Transplant       Date:  2017-08-24

8.  Clinical significance of CCR7+CD8+ T cells in kidney transplant recipients with allograft rejection.

Authors:  Kyoung Woon Kim; Bo-Mi Kim; Kyoung Chan Doh; Mi-La Cho; Chul Woo Yang; Byung Ha Chung
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

9.  Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients.

Authors:  Kyoung Woon Kim; Bo-Mi Kim; Kyoung Chan Doh; Chan-Duck Kim; Kyung Hwan Jeong; Sang-Ho Lee; Chul Woo Yang; Byung Ha Chung
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

10.  Reduced TCR Signaling Contributes to Impaired Th17 Responses in Tolerant Kidney Transplant Recipients.

Authors:  Estefania Nova-Lamperti; Marco Romano; Sofia Christakoudi; Manohursingh Runglall; Reuben McGregor; Paula Mobillo; Yogesh Kamra; Tjir-Li Tsui; Sonia Norris; Susan John; Dominic A Boardman; Robert I Lechler; Giovanna Lombardi; Maria P Hernandez-Fuentes
Journal:  Transplantation       Date:  2018-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.